RO101042B1 - Anti-inflammatory and anti-infectious product for veterinary use - Google Patents
Anti-inflammatory and anti-infectious product for veterinary use Download PDFInfo
- Publication number
- RO101042B1 RO101042B1 RO13345988A RO13345988A RO101042B1 RO 101042 B1 RO101042 B1 RO 101042B1 RO 13345988 A RO13345988 A RO 13345988A RO 13345988 A RO13345988 A RO 13345988A RO 101042 B1 RO101042 B1 RO 101042B1
- Authority
- RO
- Romania
- Prior art keywords
- parts
- inflammatory
- veterinary use
- product
- infectious
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Produsul, conform invenției este constituit din 34,4 părți propilenglicol, 3,1 părți eritromîcînă, 1,5 părți acid, 2(4-izobutilfenil) - propionic și 1,0 părți sulfatiazol, părțile fiind exprimate în greutate.The product according to the invention consists of 34.4 parts propylene glycol, 3.1 parts erythromycin, 1.5 parts acid, 2 (4-isobutylphenyl) - propionic and 1.0 parts sulfatiazole, the parts being expressed by weight.
Description
Prezenta invenție se referă Ia un produs antiimflamator și antiinfecțios de uz veterinar, destinat vindecării leziunilor operatorii sau accidentale.The present invention relates to an anti-inflammatory and anti-infectious product for veterinary use, intended for the healing of operative or accidental injuries.
Sînt cunoscute produse medicamentoase de uz veterinar, cu acțiune dezinfectantă, care conține 10% sulfametin, 10% sulfacetamină eventual cu 10% sulfariazol și sare de sodiu, sau conține iod, clorură de benzalconiu sau clorură de cetilpiridină dizolvate în aleool etilic și dizolvate într-un gel alcoolic de carboxiviniîpolimeri și alcool cetilic.Veterinary medicinal products with disinfectant action, containing 10% sulfametin, 10% sulfacetamine, possibly 10% sulfariazole and sodium salt, or containing iodine, benzalkonium chloride or cetylpyridine chloride dissolved in ethyl alcohol and dissolved in alcohol are known. an alcohol gel of carboxyvinyl polymers and cetyl alcohol.
Scopul prezentei invenții este de a lărgi gama produselor meidcamentoase de uz veterinar, cu acțiunedezinfectantă.The object of the present invention is to expand the range of medicinal products for veterinary use, with disinfectant action.
Problema pe care o rezolvă invenția este stabilirea raportului optim de asociere dintre ingrediente.The problem solved by the invention is to establish the optimal ratio of association between ingredients.
Produsul medicamentos conform invenției este constituit din 34,4 părți propilenglicol, 3,1 părți eritromicină, 1,5 părți acid 2(4-izohutilfenil)-propionic șî 1,0 părți sulfatiazol, părțile fiind exprimate în greutate.The drug product according to the invention consists of 34.4 parts propylene glycol, 3.1 parts erythromycin, 1.5 parts 2 (4-isohutylphenyl) -propionic acid and 1.0 parts sulfatiazole, the parts being expressed by weight.
Se dă. în continuare un exemplu de realizare a invenției.It is given. The following is an embodiment of the invention.
Intr-un reactor emailat sau confecționat din V2A, prevăzut cu agitator, termometru și manta de încălzire - răcire, se încarcă 94,4 kg propilenglicol, pornîndu-se agitarea, apoi se adaugă 3,1 kg eritromocină bază, 1,50 kg acid 2(4-izobutilfenil) propionic și 1,00 kg sulfatiazol. Se închide capacul reactorului și se încălzește conținutul la 45,..55°C După dizolvarea componentelor (1-2 h), soluția se răcește Ia 18...20°C.In a reactor enamelled or made of V2A, equipped with a stirrer, thermometer and heating-cooling jacket, 94.4 kg of propylene glycol is loaded, stirring is started, then 3.1 kg of erythromycin base, 1.50 kg of acid is added. 2 (4-isobutylphenyl) propionic and 1.00 kg sulfatiazole. Close the reactor lid and heat the contents to 45, .. 55 ° C After dissolving the components (1-2 h), the solution is cooled to 18 ... 20 ° C.
Produsul se filtrează printr-un filtru Seitz, după care se îmbuteliază în atmosferă de protoxid de azot, bioxid de carbon cu azot sau amestec azot -pretoxid de azot sau bioxid de carbon.The product is filtered through a Seitz filter, after which it is bottled in the atmosphere with nitrogen oxide, carbon dioxide with nitrogen or mixture of nitrogen - nitrogen oxide or carbon dioxide.
Presurizarea se face prin impact sau prin metoda eaalării presiunii.Pressurization is done by impact or by the method of pressure analysis.
Compoziția mai poate fi folosită ca tare, prin badijonare, sau îmbuteliată în flacon, la care se poate aplica un pulverizator manual.The composition can also be used as hard, by tapping, or bottled in the bottle, to which a hand spray can be applied.
Produsul s-a dovedit a fi eficace prin efectul bacteriostatic șî bacteriolitîc asupra germenilor din rană, jugnlînd infecția în primele 3...4 zile după tratament, spectrul de acțiune cuprinzînd ceai gram pozitiv, ceai gram negativ, clostridii etc.The product has been shown to be effective by the bacteriostatic and bacteriolytic effect on the germs of the wound, judging the infection in the first 3 ... 4 days after treatment, the spectrum of action comprising gram positive tea, gram negative tea, clostridia etc.
Efectul antiinflamator al acidului 2(4-izobutiIfeniI) propionic se materializează printr-o analgezic locală și o îmbunătățire a nutriției țesuturilor bolnave.The anti-inflammatory effect of propionic acid 2 (4-isobutylphenyl) is materialized by a local analgesic and an improvement in the nutrition of diseased tissues.
Compoziția este eficace în răni accidentale și operatorii, răni infectate, excoriații, răni decubitale, dermatite, crevase, ariceală, bursită, tromboflebită, varice, javart cutanat, javart tendinos, artrită deschisă, pododermite, arapod, panarițîu, ulcerul selei, etite.The composition is effective in accidental and operative wounds, infected wounds, excoriations, decubitus wounds, dermatitis, crevices, hives, bursitis, thrombophlebitis, varicose veins, skin javart, tendon javart, open arthritis, pododermitis, arapod, panariitis, ulcer.
Medicamentul conform invenției prezintă următoarele avantaje:The medicament according to the invention has the following advantages:
- este bine suportat de organism și are un spectru de acțiune larg;- it is well supported by the body and has a wide range of action;
- are penetrabilitate bună și asigura o vindecare rapidă (4...8 zile).- has good penetrability and ensures a rapid healing (4 ... 8 days).
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RO13345988A RO101042B1 (en) | 1988-05-11 | 1988-05-11 | Anti-inflammatory and anti-infectious product for veterinary use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RO13345988A RO101042B1 (en) | 1988-05-11 | 1988-05-11 | Anti-inflammatory and anti-infectious product for veterinary use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RO101042B1 true RO101042B1 (en) | 1993-02-15 |
Family
ID=20121649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RO13345988A RO101042B1 (en) | 1988-05-11 | 1988-05-11 | Anti-inflammatory and anti-infectious product for veterinary use |
Country Status (1)
| Country | Link |
|---|---|
| RO (1) | RO101042B1 (en) |
-
1988
- 1988-05-11 RO RO13345988A patent/RO101042B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6432426B2 (en) | Non-staining topical iodine composition and method | |
| CA1182043A (en) | Germicidal composition | |
| EP2566488B1 (en) | Povidone-iodine topical composition | |
| US6261577B1 (en) | Non-staining topical iodine composition and method | |
| FI955124A0 (en) | Mixture of veterinary medicinal products containing a proton pump inhibitor | |
| MX2012001415A (en) | Hydrogel formulation comprising oxidative reductive potential water. | |
| Biro et al. | Ethylene oxide burns: a hospital outbreak involving 19 women | |
| EP0739209A1 (en) | Method for treatment of papulo-pustules and comedones of the skin | |
| RO101042B1 (en) | Anti-inflammatory and anti-infectious product for veterinary use | |
| EP2897688B1 (en) | Viscous haemostatic compostions and method of treatment | |
| US4849221A (en) | Pharmaceutical product, containing a mixture of benzoic acid, phenol and an alkali fluoride, for the topical treatment of herpes virus efflorescences, and method for treatment of herpes simplex efflorescences in the human | |
| US20050266098A1 (en) | Composition for treatment of a hydrofluoric acid burn | |
| EP1744769A1 (en) | Non-staining topical iodine composition | |
| KR100366684B1 (en) | Oil-based topical preparation including ozone and method of preparation thereof | |
| CN1047521C (en) | Medicine for curing dermatophyte | |
| CN111346049A (en) | Preparation method of skin and mucous membrane disinfectant | |
| EP0477143B1 (en) | Pharmaceutical composition having a cicatrising effect | |
| RU2232711C1 (en) | Method of production of xenon difluoride, its rectification and application | |
| RU2014085C1 (en) | Antimicrobial composition | |
| KR960004499B1 (en) | Making-up soap composition | |
| RU2243151C2 (en) | Method of preparing oxygen compounds of xenon and utilization thereof | |
| SU1391653A1 (en) | Agent for prophylaxis and treatment of gastroenteritis of pigs | |
| RU2083216C1 (en) | A product | |
| Tan et al. | Allergic contact dermatitis from Steret® swab. | |
| EP1691613A2 (en) | Disinfecting composition, preparation and use thereof |